LTA4 hydrolase inhibitors

Details LTA4 hydrolase inhibitors LTA4 hydrolase inhibitors

2005-04-12

2005-04-12

Raymond, Richard L. (Department: 1624)

Drug, bio-affecting and body treating compositions

Designated organic active ingredient containing

Having -c-, wherein x is chalcogen, bonded directly to...

C514S318000, C514S326000, C514S327000, C514S333000, C514S334000, C514S335000, C514S345000, C514S571000, C514S572000, C546S186000, C546S188000, C546S191000, C546S193000, C546S208000, C546S212000, C546S214000, C546S216000, C546S229000, C546S238000, C549S060000, C549S065000, C549S066000, C549S077000, C549S497000, C549S499000, C560S045000, C560S121000, C560S123000, C560S124000, C560S126000, C562S444000, C562S452000, C562S498000, C562S500000, C562S503000, C562S505000

Reexamination Certificate

active

06878723

ABSTRACT:
The invention concerns compounds inhibiting LTA4hydrolase of formula (I). The invention also concerns their therapeutic, in particular anti-inflammatory, applications.

REFERENCES:
patent: 3553258 (1971-01-01), Kaiser et al.
patent: 4341767 (1982-07-01), Nestor et al.
patent: 5362899 (1994-11-01), Campbell
Organic Chemistry, 2ndEdition. McMurry. pp. 970-974. Brooks/Cole Publishing Co. (1988).*
Takamura et al, “Optically Active Amino Acids. XV. alpha-Alkyl-alpha-amino acids. 8. 2-amino-2-methyl-3-buteneoic acid” Chem. Pharm. Bull. vol. 15(11), pp. 1776-1784 (1967).*
Coulter et al, “Structural and Conformational Analogues of I-Methionine as Inhibitors of the Enzymatic Synthesis of S-Adenosyl Methionine” Molecular Pharmacology, vol. 10, pp. 305-314 (1974).*
Wilson and Gisvold's Textbook of Organic, Medicinal and Pharmaceutical Chemistry, 9th ed. J.B. Lippincott Co., 1991.*
Lipinski et al, “Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings” Adv. Drug Delivery Rev. vol. 23, pp. 3-25 (1997).*
Liao et al, “Novel and Known Constituents from Buddleja Species and Their Activity against Leukocyte Eicosanoid Generation” J. Nat. Prod. vol. 62, pp. 1241-1245 (1999).*
Cichewicz et al, “Dimerization of Resveratrol by the Grapevine Pathogen Botrytis cinerea” J. Nat. Prod. vol. 63, pp. 29-33 (2000).*
Botting, Regina M., “Mechanism of Action of Acetaminophen: Is There a Cyclooxenase 3?” Clinical Infectious Diseases, 31 Suppl. 5, pp. S202-S210 (Oct. 2000).*
Likhitwitayawuid et al, “Flavonoids and Stilbenoids with COX-1 and COX-2 Inhibitory Activity from Dracaena lourein” Planta Medica, vol. 68(9), pp. 841-843 (Sep. 2002).

Affiliated with

Also associated with

Rating

LTA4 hydrolase inhibitors does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with LTA4 hydrolase inhibitors, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and LTA4 hydrolase inhibitors will most certainly appreciate the feedback.

Rate now

Comments { 0 }

Profile ID: LFUS-PAI-O-3430432